iRFP-C1 Citations (3)
Originally described in: Bright and stable near-infrared fluorescent protein for in vivo imaging.Filonov GS, Piatkevich KD, Ting LM, Zhang J, Kim K, Verkhusha VV Nat Biotechnol. 2011 Jul 17. doi: 10.1038/nbt.1918. PubMed Journal
Articles Citing iRFP-C1
Articles |
---|
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction. Carbajosa S, Pansa MF, Paviolo NS, Castellaro AM, Andino DL, Nigra AD, Garcia IA, Racca AC, Rodriguez-Berdini L, Angiolini V, Guantay L, Villafanez F, Federico MB, Rodriguez-Baili MC, Caputto BL, Drewes G, Madauss KP, Gloger I, Fernandez E, Gil GA, Bocco JL, Gottifredi V, Soria G. Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19. PubMed |
Vasodilator-stimulated phosphoprotein (VASP) is recruited into dendritic spines via G-actin-dependent mechanism and contributes to spine enlargement and stabilization. Iwasaki K, Obashi K, Okabe S. Eur J Neurosci. 2020 Feb;51(3):806-821. doi: 10.1111/ejn.14634. Epub 2019 Dec 18. PubMed |
Spatiotemporal control of phosphatidic acid signaling with optogenetic, engineered phospholipase Ds.
Tei R, Baskin JM.
J Cell Biol. 2020 Mar 2;219(3). pii: 133675. doi: 10.1083/jcb.201907013.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.